| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A retrospective survey of the safety of trivalent influenza vaccine among adults working in healthcare settings in south metropolitan Perth, Western Australia, in 2010
|
McEvoy, Suzanne P.
|
|
2012
|
30 |
17 |
p. 2801-2804
4 p.
|
artikel
|
| 2 |
CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals
|
Auten, Matthew W.
|
|
2012
|
30 |
17 |
p. 2768-2777
10 p.
|
artikel
|
| 3 |
Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus
|
Graham, Simon P.
|
|
2012
|
30 |
17 |
p. 2742-2748
7 p.
|
artikel
|
| 4 |
Combining bacterial-immunotherapy with therapeutic antibodies: A novel therapeutic concept
|
Klier, Ulrike
|
|
2012
|
30 |
17 |
p. 2786-2794
9 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2012
|
30 |
17 |
p. CO2-
1 p.
|
artikel
|
| 6 |
Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis
|
Betancourt, Miguel Angel
|
|
2012
|
30 |
17 |
p. 2760-2767
8 p.
|
artikel
|
| 7 |
Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice?
|
Bilcke, Joke
|
|
2012
|
30 |
17 |
p. 2795-2800
6 p.
|
artikel
|
| 8 |
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age
|
Van Der Meeren, Olivier
|
|
2012
|
30 |
17 |
p. 2710-2714
5 p.
|
artikel
|
| 9 |
Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form
|
Pattani, Aditya
|
|
2012
|
30 |
17 |
p. 2778-2785
8 p.
|
artikel
|
| 10 |
Potential impact of accelerating the primary dose of rotavirus vaccine in infants
|
Halvorson, Elizabeth E.
|
|
2012
|
30 |
17 |
p. 2738-2741
4 p.
|
artikel
|
| 11 |
Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination
|
Hung, Ivan F.N.
|
|
2012
|
30 |
17 |
p. 2707-2708
2 p.
|
artikel
|
| 12 |
Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines
|
Hess, Ralf D.
|
|
2012
|
30 |
17 |
p. 2715-2727
13 p.
|
artikel
|
| 13 |
Reply to “Preparing for the next public debate: Universal vaccination against hepatitis B”
|
van Rijswoud, Erwin
|
|
2012
|
30 |
17 |
p. 2709-
1 p.
|
artikel
|
| 14 |
The relationship between pneumococcal serotypes and antibiotic resistance
|
Song, Jae-Hoon
|
|
2012
|
30 |
17 |
p. 2728-2737
10 p.
|
artikel
|
| 15 |
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein
|
Dey, Antu K.
|
|
2012
|
30 |
17 |
p. 2749-2759
11 p.
|
artikel
|
Tijdschrift beschrijving